Orphan Drug Manufacturers To Discuss Easier Drug Access To Rare Disease Patients Globally, 9-11 April 2013, Washington DC

Main Category: Conferences
Article Date: 14 Jan 2013 - 4:00 PST

Current ratings for:
Orphan Drug Manufacturers To Discuss Easier Drug Access To Rare Disease Patients Globally, 9-11 April 2013, Washington DC

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Though making headway in developed orphan drug markets such as US, Europe, Australia and some countries in Asia, rare disease patients in the rest of the world have yet to see the light of day.

Over 400 biotechs, pharma, research institutions and regulators will gather at the World Orphan Drug Congress USA in Washington DC on April 9-11, 2013. Key speakers include Flemming Ornskov, Shire's Chief Executive Designate; Charles Johnson, Vice President, Respiratory Medicine from Vertex Pharmaceuticals; Jimmy Lin, Founder & President of the Rare Genomics Institute; and, Martine Zimmerman, Executive Director, Global Regulatory Affairs from Alexion Pharmaceuticals.

This conference and expo provides a platform for key movers and shakers of the orphan drug industry to come together and discover partnerships and collaborations to expedite orphan drugs to patients globally.

Various facets to highlight key needs of the industry are as follows: Participants will learn: To register or learn more visit http://www.terrapinn.com/orphandrug

CONTACT:
Caroline Hornby,
Marketing Director
 Terrapinn

caroline.hornby (at) terrapinn.com

+1 646 619 1792

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our conferences section for the latest news on this subject.
About Terrapinn:
Terrapinn is a business media company. Our products are trade exhibitions, conferences, training solutions and electronic and print publications. More information and a schedule of our events can be found at http://www.terrapinn.com.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Terrapinn. "Orphan Drug Manufacturers To Discuss Easier Drug Access To Rare Disease Patients Globally, 9-11 April 2013, Washington DC." Medical News Today. MediLexicon, Intl., 14 Jan. 2013. Web.
20 Jun. 2013. <http://www.medicalnewstoday.com/releases/254901.php>

APA
Terrapinn. (2013, January 14). "Orphan Drug Manufacturers To Discuss Easier Drug Access To Rare Disease Patients Globally, 9-11 April 2013, Washington DC." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/254901.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Orphan Drug Manufacturers To Discuss Easier Drug Access To Rare Disease Patients Globally, 9-11 April 2013, Washington DC'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Conferences

Most Popular Articles



Follow Our Conferences News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Conferences Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »